Works by Strutz, Jasmin


Results: 9
    1

    The Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitor Empagliflozin Reverses Hyperglycemia-Induced Monocyte and Endothelial Dysfunction Primarily through Glucose Transport-Independent but Redox-Dependent Mechanisms.

    Published in:
    Journal of Clinical Medicine, 2023, v. 12, n. 4, p. 1356, doi. 10.3390/jcm12041356
    By:
    • Semo, Dilvin;
    • Obergassel, Julius;
    • Dorenkamp, Marc;
    • Hemling, Pia;
    • Strutz, Jasmin;
    • Hiden, Ursula;
    • Müller, Nicolle;
    • Müller, Ulrich Alfons;
    • Zulfikar, Sajan Ahmad;
    • Godfrey, Rinesh;
    • Waltenberger, Johannes
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9